-
1
-
-
10644263173
-
Keratoacanthoma
-
Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. New York: McGraw-Hill
-
Cerroni L, Kerl H. Keratoacanthoma. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatricks dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2003:760-767
-
(2003)
Fitzpatricks Dermatology in General Medicine. 6th Ed.
, pp. 760-767
-
-
Cerroni, L.1
Kerl, H.2
-
2
-
-
1542318591
-
Keratoacanthoma: A clinico-pathologic enigma
-
Schwartz RA. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg 2004;30:326-333
-
(2004)
Dermatol Surg
, vol.30
, pp. 326-333
-
-
Schwartz, R.A.1
-
3
-
-
0347951007
-
The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: An overview
-
Stockfleth E, Trefzer U, Garcia-Bartels C, Wegner T, Schmook T, Sterry W. The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview. Br J Dermatol 2003;149(Suppl 66):53-56
-
(2003)
Br J Dermatol
, vol.149
, Issue.SUPPL. 66
, pp. 53-56
-
-
Stockfleth, E.1
Trefzer, U.2
Garcia-Bartels, C.3
Wegner, T.4
Schmook, T.5
Sterry, W.6
-
4
-
-
0742289604
-
Two cases of squamous cell carcinoma treated with topical imiquimod 5%
-
Oster-Schmidt C. Two cases of squamous cell carcinoma treated with topical imiquimod 5%. J Eur Acad Dermatol Venereol 2004;18:93-95
-
(2004)
J Eur Acad Dermatol Venereol
, vol.18
, pp. 93-95
-
-
Oster-Schmidt, C.1
-
5
-
-
0347320544
-
Summary of actinic keratosis studies with imiquimod 5% cream
-
Tran H, Chen K, Shumack S. Summary of actinic keratosis studies with imiquimod 5% cream. Br J Dermatol 2003;149(Suppl 66):37-39
-
(2003)
Br J Dermatol
, vol.149
, Issue.SUPPL. 66
, pp. 37-39
-
-
Tran, H.1
Chen, K.2
Shumack, S.3
-
6
-
-
0037285862
-
Topical treatment with imiquimod may induce regression of facial keratoacanthoma
-
Dendorfer M, Oppel T, Wollenberg A, Prinz JC. Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Eur J Dermatol 2003;13:80-82
-
(2003)
Eur J Dermatol
, vol.13
, pp. 80-82
-
-
Dendorfer, M.1
Oppel, T.2
Wollenberg, A.3
Prinz, J.C.4
-
7
-
-
1842591903
-
Imiquimod as a possible treatment for keratoacanthoma
-
Bhatia N. Imiquimod as a possible treatment for keratoacanthoma. J Drugs Dermatol 2004;3:71-74
-
(2004)
J Drugs Dermatol
, vol.3
, pp. 71-74
-
-
Bhatia, N.1
-
8
-
-
0347951018
-
Imiquimod: Modes of action
-
Sauder DN. Imiquimod: modes of action. Br J Dermatol 2003;149(S66):5-8
-
(2003)
Br J Dermatol
, vol.149
, Issue.S66
, pp. 5-8
-
-
Sauder, D.N.1
-
9
-
-
0028114588
-
Evidence that regression in keratoacanthoma is immunologically mediated: A comparison with squamous cell carcinoma
-
Patel A, Halliday GM, Cooke BE, Barnetson RS. Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol 1994;131:789-798
-
(1994)
Br J Dermatol
, vol.131
, pp. 789-798
-
-
Patel, A.1
Halliday, G.M.2
Cooke, B.E.3
Barnetson, R.S.4
-
10
-
-
0002356857
-
Tumors and cysts of the epidermis
-
Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, editors. Philadelphia: Lippincott-Raven
-
Kirkham N. Tumors and cysts of the epidermis. In: Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, editors. Levers histopathology of the skin. 8th ed. Philadelphia: Lippincott-Raven, 1997:731-734
-
(1997)
Levers Histopathology of the Skin. 8th Ed.
, pp. 731-734
-
-
Kirkham, N.1
-
11
-
-
0042160130
-
Imiquimod 5% cream: A treatment option for keratoacanthoma?
-
Prinz JC. Imiquimod 5% cream: a treatment option for keratoacanthoma? Eur J Dermatol 2003;13:415
-
(2003)
Eur J Dermatol
, vol.13
, pp. 415
-
-
Prinz, J.C.1
|